Global Viral Inactivation Market 2019 Key highlights, classification, estimates, Overview & Forecast

The major drivers for the Viral Inactivation Market are rapid growth in pharmaceutical and biotechnology industries and a strong trend of R&D investments in the life sciences industry. An increasing number of new drug launches, rise in chronic disease burden, and increasing government support for the pharmaceutical and biotechnology industries will also aid the growth of this market.

Viral inactivation testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

According to Latest Market research report Published by MarketsandMarkets the “Viral Inactivation Market Size, Share, Demand and Growth Analysis, forecast” the Global Market is expected to reach the US $ 573.0 Million, at CAGR of 12.3%.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017

Expansions and product launches were the primary growth strategies adopted by major players to expand their product portfolio in the global Viral Inactivation Market.

key players operating in the Global Viral Inactivation Market;

Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).

Major Drivers Impacting the Viral Inactivation Market;

· Rapid Growth in Pharmaceutical and Biotechnology Industries

· Increasing Number of New Drug Launches

· Strong R&D Investments in the Life Sciences Industry

· Increasing Government Support for Pharmaceutical and Biotechnology Industries

· High Incidence and Large Economic Burden of Chronic Diseases

Speak to Our Subject Expert:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121427017

Global Viral Inactivation Market Segmentation:

The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Based on geography the market is segmented into North America, Europe, Asia and Rest of the World (RoW).

Based on end-user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017

Viral Inactivation Market by Geography:

• North America
• Europe
• Asia
• Rest of the World